Michael Yang

Michael Yang

Director/Miembro de la Junta en PACIRA BIOSCIENCES, INC. .

Fortuna: 1 M $ al 31/05/2026

64 años
Health Technology
Consumer Services
Finance

Perfil

Michael J.
Yang
is currently an Independent Director at Ionis Pharmaceuticals, Inc. and Pacira Biosciences, Inc., both starting in 2023.
Mr. Yang is also an Operating Partner at ARTIS Ventures Management LP.
Former roles include President, Chief Executive Officer & Director at ViaCyte, Inc. from 2021 to 2022; Director at Akcea Therapeutics, Inc. in 2020; President at Johnson & Johnson; Chief Commercial Officer & Executive Vice President at ACADIA Pharmaceuticals, Inc. from 2017 to 2021; Vice President-Sales & Marketing at Ortho Biotech, Inc.; General Manager at Veridex LLC and Therakos LLC; President at Janssen Biotech, Inc.; and President-Immunology at Janssen Pharmaceuticals, Inc. from 2013 to 2017.
Education includes undergraduate studies at San Diego State University.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
31/03/2026 7.940 ( 0 % ) 607 410 $ 31/05/2026
10/06/2026 19.798 ( 0,05 % ) 459 710 $ 31/05/2026

Cargos activos de Michael Yang

EmpresasCargoInicio
PACIRA BIOSCIENCES, INC. Director/Miembro de la Junta 10/10/2023
IONIS PHARMACEUTICALS, INC. Director/Miembro de la Junta 14/12/2023
Inversor de Capital Privado -

Antiguos cargos conocidos de Michael Yang.

EmpresasCargoFin
Director Ejecutivo 01/10/2022
ACADIA PHARMACEUTICALS INC. Corporate Officer/Principal 29/01/2021
AKCEA THERAPEUTICS, INC. Director/Miembro de la Junta 01/12/2020
Corporate Officer/Principal 01/03/2017
JOHNSON & JOHNSON Presidente -
Ver el detalle de la experiencia de Michael Yang.

Formación de Michael Yang.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

54

Relaciones de 1er grado

13

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas13

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Ortho Biotech, Inc.

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Finance

Health Technology

-40%: Ampliación de plazo extraordinaria
d
:
:
APROVECHAR LA PROMOCIÓN